59 related articles for article (PubMed ID: 36061170)
1. Pan-cancer proteogenomics connects oncogenic drivers to functional states.
Li Y; Porta-Pardo E; Tokheim C; Bailey MH; Yaron TM; Stathias V; Geffen Y; Imbach KJ; Cao S; Anand S; Akiyama Y; Liu W; Wyczalkowski MA; Song Y; Storrs EP; Wendl MC; Zhang W; Sibai M; Ruiz-Serra V; Liang WW; Terekhanova NV; Rodrigues FM; Clauser KR; Heiman DI; Zhang Q; Aguet F; Calinawan AP; Dhanasekaran SM; Birger C; Satpathy S; Zhou DC; Wang LB; Baral J; Johnson JL; Huntsman EM; Pugliese P; Colaprico A; Iavarone A; Chheda MG; Ricketts CJ; Fenyö D; Payne SH; Rodriguez H; Robles AI; Gillette MA; Kumar-Sinha C; Lazar AJ; Cantley LC; Getz G; Ding L;
Cell; 2023 Aug; 186(18):3921-3944.e25. PubMed ID: 37582357
[TBL] [Abstract][Full Text] [Related]
2. PROBING CANCER SIGNALING WITH RESONANT WAVEGUIDE GRATING BIOSENSORS.
Fang Y
Expert Opin Drug Discov; 2010 Dec; 5(12):1237-1248. PubMed ID: 21113317
[TBL] [Abstract][Full Text] [Related]
3. Correction to "Pan-cancer analysis of the oncogenic role of HNRNPR in human tumors".
Cell Biol Int; 2024 Feb; 48(2):229. PubMed ID: 38084795
[No Abstract] [Full Text] [Related]
4. Cellular neighborhood analysis in spatial omics reveals new tissue domains and cell subtypes.
Ruitenberg MJ; Nguyen QH
Nat Genet; 2024 Mar; 56(3):362-364. PubMed ID: 38413724
[No Abstract] [Full Text] [Related]
5. Repurposing Synthetic Congeners of a Natural Product Aurone Unveils a Lead Antitumor Agent Inhibiting Folded P-Loop Conformation of MET Receptor Tyrosine Kinase.
Hassan AHE; Wang CY; Lee CJ; Jeon HR; Choi Y; Moon S; Lee CH; Kim YJ; Cho SB; Mahmoud K; El-Sayed SM; Lee SK; Lee YS
Pharmaceuticals (Basel); 2023 Nov; 16(11):. PubMed ID: 38004462
[TBL] [Abstract][Full Text] [Related]
6. Non-Association of Driver Alterations in PTEN with Differential Gene Expression and Gene Methylation in IDH1 Wildtype Glioblastomas.
Mallik MK; Majumdar K; Mujtaba S
Brain Sci; 2023 Jan; 13(2):. PubMed ID: 36831729
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic signaling pathway dysregulation landscape reveals the role of pathways at multiple omics levels in pan-cancer.
Wang N; He DN; Wu ZY; Zhu X; Wen XL; Li XH; Guo Y; Wang HJ; Wang ZZ
Front Genet; 2022; 13():916400. PubMed ID: 36061170
[TBL] [Abstract][Full Text] [Related]
8. A comprehensive overview of oncogenic pathways in human cancer.
Li F; Wu T; Xu Y; Dong Q; Xiao J; Xu Y; Li Q; Zhang C; Gao J; Liu L; Hu X; Huang J; Li X; Zhang Y
Brief Bioinform; 2020 May; 21(3):957-969. PubMed ID: 31155677
[TBL] [Abstract][Full Text] [Related]
9. Identifying individualized risk subpathways reveals pan-cancer molecular classification based on multi-omics data.
Xu Y; Wang J; Li F; Zhang C; Zheng X; Cao Y; Shang D; Hu C; Xu Y; Mi W; Li X; Cao Y; Zhang Y
Comput Struct Biotechnol J; 2022; 20():838-849. PubMed ID: 35222843
[TBL] [Abstract][Full Text] [Related]
10. Integration of multi-omics data reveals a novel hybrid breast cancer subtype and its biomarkers.
Wang ZZ; Li XH; Wen XL; Wang N; Guo Y; Zhu X; Fu SH; Xiong FF; Bai J; Gao XL; Wang HJ
Front Oncol; 2023; 13():1130092. PubMed ID: 37064087
[TBL] [Abstract][Full Text] [Related]
11. Pan-cancer onco-signatures reveal a novel mitochondrial subtype of luminal breast cancer with specific regulators.
Simeone I; Ceccarelli M
J Transl Med; 2023 Jan; 21(1):55. PubMed ID: 36717859
[TBL] [Abstract][Full Text] [Related]
12. Investigation of lipid metabolism dysregulation and the effects on immune microenvironments in pan-cancer using multiple omics data.
Hao Y; Li D; Xu Y; Ouyang J; Wang Y; Zhang Y; Li B; Xie L; Qin G
BMC Bioinformatics; 2019 May; 20(Suppl 7):195. PubMed ID: 31074374
[TBL] [Abstract][Full Text] [Related]
13. Metabolic-Pathway-Based Subtyping of Triple-Negative Breast Cancer Reveals Potential Therapeutic Targets.
Gong Y; Ji P; Yang YS; Xie S; Yu TJ; Xiao Y; Jin ML; Ma D; Guo LW; Pei YC; Chai WJ; Li DQ; Bai F; Bertucci F; Hu X; Jiang YZ; Shao ZM
Cell Metab; 2021 Jan; 33(1):51-64.e9. PubMed ID: 33181091
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
